Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€241.25

€241.25

-1.230%
-3.0
-1.230%
€334.34
 
21:05 / Tradegate WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

UnitedHealth Group Inc. Stock

A loss of -1.230% shows a downward development for UnitedHealth Group Inc..
The stock is one of the favorites of our community with 76 Buy predictions and 2 Sell predictions.
As a result the target price of 334 € shows a positive potential of 38.45% compared to the current price of 241.25 € for UnitedHealth Group Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for UnitedHealth Group Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of UnitedHealth Group Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of UnitedHealth Group Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
UnitedHealth Group Inc. -1.230% -19.056% -12.596% -52.738% -12.830% -45.401% -11.166%
Cigna Corp. 0.530% -4.986% -3.326% -22.186% -3.305% -20.088% 26.846%
Centene Corp. 0.320% -5.719% 5.031% -40.658% 5.365% -47.394% -26.847%
Humana Inc. 0.300% -27.483% -25.205% -41.879% -25.205% -62.944% -48.022%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

When evaluating the financials of UnitedHealth Group (UNH), it becomes apparent that this company stands as a formidable entity within the Healthcare Providers & Services industry. The metrics and trends presented in the financial statements, alongside the ratios provided, paint a picture of robust growth prospects, operational efficiency, and a sound balance sheet. However, not all appears pristine; there are nuances worth exploring that highlight both strengths and potential pitfalls.

Pros of UnitedHealth's Financials

Strong Revenue Streams: UnitedHealth has consistently shown impressive revenue growth, with total revenues amounting to approximately $385.44 billion over the last twelve months. The company's ability to generate significant top-line revenue is indicative of its market strength and wide-ranging service offerings.

Comments

Prediction Buy
Perf. (%) 0.23%
Target price 274.615
Change
Ends at 30.01.27

UnitedHealth Group (NYSE:UNH) had its price target lowered by analysts at Barclays PLC from $391.00 to $327.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.25%
Target price 310.726
Change
Ends at 30.01.27

UnitedHealth Group (NYSE:UNH) had its price target lowered by analysts at Wells Fargo & Company from $400.00 to $370.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -1.63%
Target price 283.526
Change
Ends at 28.01.27

UnitedHealth Group (NYSE:UNH) had its price target lowered by analysts at Jefferies Financial Group Inc. from $418.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat
Show more

News

Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?: https://g.foolcdn.com/editorial/images/853363/stock-chart-falling-with-man-holding-hand-to-head.jpg
Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?

UnitedHealth Group (NYSE: UNH) announced its 2025 full-year and fourth-quarter results on Tuesday, Jan. 27, 2026. Despite reporting better-than-expected earnings, UnitedHealth's stock plummeted 20%.

Why UnitedHealth Group Stock Just Bounced Back: https://g.foolcdn.com/editorial/images/853394/doctor-in-labcoat-drawing-a-heartbeat-in-red.jpg
Why UnitedHealth Group Stock Just Bounced Back

Shares of UnitedHealth Group (NYSE: UNH) stock crashed nearly 20% yesterday after reporting a tiny sales miss in its Q4 earnings report -- and a gigantic disappointment on profits.

Although

Here Are the 2 Headwinds Driving UnitedHealth's 20% Decline: https://g.foolcdn.com/editorial/images/853307/gettyimages-1139704348.jpg
Here Are the 2 Headwinds Driving UnitedHealth's 20% Decline

UnitedHealth Group (NYSE: UNH) faced a number of challenges in 2025 that weighed on stock performance: from the higher costs of healthcare, which hurt earnings, to a Justice Department probe into